Cargando…

Fecal Microbiota Transplantation in Inflammatory Bowel Disease: Beyond the Excitement

The purpose of this article is to perform a systematic review of the literature on the use of fecal microbiota transplantation (FMT) in inflammatory bowel disease (IBD). There is an increasing interest of both physicians and patients in assessing the possible role of the FMT in the treatment of IBD....

Descripción completa

Detalles Bibliográficos
Autores principales:	Ianiro, Gianluca, Bibbò, Stefano, Scaldaferri, Franco, Gasbarrini, Antonio, Cammarota, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2014
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616323/ https://www.ncbi.nlm.nih.gov/pubmed/25340496 http://dx.doi.org/10.1097/MD.0000000000000097

Ejemplares similares

Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center
por: Ianiro, Gianluca, et al.
Publicado: (2021)

Fecal Microbiota Transplantation: Screening and Selection to Choose the Optimal Donor
por: Bibbò, Stefano, et al.
Publicado: (2020)

Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study
por: Ianiro, Gianluca, et al.
Publicado: (2020)

Role of Microbiota and Innate Immunity in Recurrent Clostridium difficile Infection
por: Bibbò, Stefano, et al.
Publicado: (2014)

The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2020)

“Bacterial Consortium”: A Potential Evolution of Fecal Microbiota Transplantation for the Treatment of Clostridioides difficile Infection
por: Quaranta, Gianluca, et al.
Publicado: (2022)

Efficacy of oral fecal microbiota transplantation in recurrent bowel disease: A protocol for systematic review and meta-analysis
por: Chen, Qin, et al.
Publicado: (2022)

COVID-19 as a trigger of irritable bowel syndrome: A review of potential mechanisms
por: Settanni, Carlo Romano, et al.
Publicado: (2021)

Treatment of Recurrent Clostridioides difficile Infection Using Fecal Microbiota Transplantation in Iranian Patients with Underlying Inflammatory Bowel Disease
por: Azimirad, Masoumeh, et al.
Publicado: (2020)

Risk Factors, Diagnosis, and Management of Clostridioides difficile Infection in Patients with Inflammatory Bowel Disease
por: Del Vecchio, Livio Enrico, et al.
Publicado: (2022)

Gut microbiota and immunotherapy of renal cell carcinoma
por: Bibbò, Stefano, et al.
Publicado: (2023)

The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2023)

Fecal calprotectin levels are elevated in transthyretin amyloidosis patients with gastrointestinal manifestations
por: Nakov, Radislav, et al.
Publicado: (2020)

Role of gut microbiome on immunotherapy efficacy in melanoma
por: Bibbò, Stefano, et al.
Publicado: (2021)

Clinical efficacy maintains patients’ positive attitudes toward fecal microbiota transplantation
por: Xu, Lijuan, et al.
Publicado: (2016)

Fecal microbiota transplantation is a rescue treatment modality for refractory ulcerative colitis
por: Uygun, Ahmet, et al.
Publicado: (2017)

Prior Misdiagnosis of Celiac Disease Is Common Among Patients Referred to a Tertiary Care Center: A Prospective Cohort Study
por: Ianiro, Gianluca, et al.
Publicado: (2016)

Probiotics, prebiotics, antibiotic, Chinese herbal medicine, and fecal microbiota transplantation in irritable bowel syndrome: Protocol for a systematic review and network meta-analysis
por: He, Ying, et al.
Publicado: (2020)

Effectiveness of fecal microbiota transplantation for severe diarrhea after drug-induced hypersensitivity syndrome
por: Wei, Yanling, et al.
Publicado: (2019)

The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease
por: Holleran, Grainne, et al.
Publicado: (2017)

Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases
por: Ianiro, Gianluca, et al.
Publicado: (2022)

Fecal Microbiota Transplantation as a Novel Therapy for Ulcerative Colitis: A Systematic Review and Meta-Analysis
por: Sun, Dali, et al.
Publicado: (2016)

Bacillus clausii for the Treatment of Acute Diarrhea in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Ianiro, Gianluca, et al.
Publicado: (2018)

Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease
por: Bibbò, Stefano, et al.
Publicado: (2018)

The differences between fecal microbiota and intestinal fluid microbiota in colon polyps: An observational study
por: Zhou, Xi, et al.
Publicado: (2021)

Thalidomide for inflammatory bowel disease: Systematic review
por: Bramuzzo, Matteo, et al.
Publicado: (2016)

Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2023)

The combined therapy of fecal microbiota transplantation and laxatives for functional constipation in adults: A systematic review and meta-analysis of randomized controlled trials
por: Fang, Sijia, et al.
Publicado: (2021)

Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent Clostridioides difficile infection in patients with inflammatory bowel disease
por: van Lingen, Emilie (E.), et al.
Publicado: (2023)

Fecal Microbiota Transplantation in Inflammatory Bowel Disease
por: Boicean, Adrian, et al.
Publicado: (2023)

Orphan patients with inflammatory bowel disease - when we treat beyond evidence
por: Privitera, Giuseppe, et al.
Publicado: (2021)

Application of fecal microbial transplantation in hepatic encephalopathy after transjugular intrahepatic portosystemic shunt
por: Li, Jun, et al.
Publicado: (2022)

Fecal Microbiota Transplantation in Patients with HBV Infection or Other Chronic Liver Diseases: Update on Current Knowledge and Future Perspectives
por: Paratore, Mattia, et al.
Publicado: (2021)

The Influence of Helicobacter pylori on Human Gastric and Gut Microbiota
por: Fiorani, Marcello, et al.
Publicado: (2023)

Pulmonary dysfunction in 114 patients with inflammatory bowel disease
por: Zhao, Yujie, et al.
Publicado: (2017)

Chronic autoimmune disorders are increased in coeliac disease: A case–control study
por: Bibbò, Stefano, et al.
Publicado: (2017)

Pneumococcal Vaccination Rates in VHA Patients With Inflammatory Bowel Disease
por: Case, David J., et al.
Publicado: (2015)

Physical activity and quality of life of patients with inflammatory bowel disease
por: Kim, Bun, et al.
Publicado: (2021)

What are the risk factors for extraintestinal manifestations in inflammatory bowel diseases?
por: Yeo, Min-Kyung, et al.
Publicado: (2023)

The Interplay between Immunity and Microbiota at Intestinal Immunological Niche: The Case of Cancer
por: Cianci, Rossella, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k40uee8i5pk3upmu99l7iatenr